Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.

Moran EE, Wang C, Katz M, Ozelius L, Schwartz A, Pavlovic J, Ortega RA, Lipton RB, Zimmerman ME, Saunders-Pullman R.

Neurobiol Aging. 2017 Oct;58:239.e1-239.e7. doi: 10.1016/j.neurobiolaging.2017.06.010. Epub 2017 Jun 24.

PMID:
28728889
2.

The Effects of Obstructive Sleep Apnea Syndrome on the Dentate Gyrus and Learning and Memory in Children.

Cha J, Zea-Hernandez JA, Sin S, Graw-Panzer K, Shifteh K, Isasi CR, Wagshul ME, Moran EE, Posner J, Zimmerman ME, Arens R.

J Neurosci. 2017 Apr 19;37(16):4280-4288. doi: 10.1523/JNEUROSCI.3583-16.2017. Epub 2017 Mar 20.

3.

The development of an experimental multiple serogroups vaccine for Neisseria meningitidis.

Pinto VB, Burden R, Wagner A, Moran EE, Lee CH.

PLoS One. 2013 Nov 14;8(11):e79304. doi: 10.1371/journal.pone.0079304. eCollection 2013.

4.

Rats learn to freeze to 22-kHz ultrasonic vocalizations through autoconditioning.

Parsana AJ, Moran EE, Brown TH.

Behav Brain Res. 2012 Jul 1;232(2):395-9. doi: 10.1016/j.bbr.2012.03.031. Epub 2012 Mar 28.

5.

Analysis of the bactericidal response to an experimental Neisseria meningitidis vesicle vaccine.

Moran EE, Burden R, Labrie JE 3rd, Wen Z, Wang XM, Zollinger WD, Zhang L, Pinto VB.

Clin Vaccine Immunol. 2012 May;19(5):659-65. doi: 10.1128/CVI.00070-12. Epub 2012 Mar 29. Erratum in: Clin Vaccine Immunol. 2012 Oct;19(10)1705.

6.

Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide.

Zollinger WD, Babcock JG, Moran EE, Brandt BL, Matyas GR, Wassef NM, Alving CR.

Vaccine. 2012 Jan 17;30(4):712-21. doi: 10.1016/j.vaccine.2011.11.084. Epub 2011 Dec 3.

PMID:
22138211
7.

An experimental outer membrane vesicle vaccine from N. meningitidis serogroup B strains that induces serum bactericidal activity to multiple serogroups.

Pinto VB, Moran EE, Cruz F, Wang XM, Fridman A, Zollinger WD, Przysiecki CT, Burden R.

Vaccine. 2011 Oct 13;29(44):7752-8. doi: 10.1016/j.vaccine.2011.07.124. Epub 2011 Aug 7.

PMID:
21827811
8.

Importance of antibodies to lipopolysaccharide in natural and vaccine-induced serum bactericidal activity against Neisseria meningitidis group B.

Schmiel DH, Moran EE, Keiser PB, Brandt BL, Zollinger WD.

Infect Immun. 2011 Oct;79(10):4146-56. doi: 10.1128/IAI.05125-11. Epub 2011 Jul 18.

9.

Kinetics and mechanism of S-nitrosothiol acid-catalyzed hydrolysis: sulfur activation promotes facile NO+ release.

Moran EE, Timerghazin QK, Kwong E, English AM.

J Phys Chem B. 2011 Mar 31;115(12):3112-26. doi: 10.1021/jp1035597. Epub 2011 Mar 8.

PMID:
21384833
10.

A phase 1 study of a meningococcal native outer membrane vesicle vaccine made from a group B strain with deleted lpxL1 and synX, over-expressed factor H binding protein, two PorAs and stabilized OpcA expression.

Keiser PB, Biggs-Cicatelli S, Moran EE, Schmiel DH, Pinto VB, Burden RE, Miller LB, Moon JE, Bowden RA, Cummings JF, Zollinger WD.

Vaccine. 2011 Feb 4;29(7):1413-20. doi: 10.1016/j.vaccine.2010.12.039. Epub 2011 Jan 1.

PMID:
21199704
11.

A phase 1 study of a group B meningococcal native outer membrane vesicle vaccine made from a strain with deleted lpxL2 and synX and stable expression of opcA.

Keiser PB, Gibbs BT, Coster TS, Moran EE, Stoddard MB, Labrie JE 3rd, Schmiel DH, Pinto V, Chen P, Zollinger WD.

Vaccine. 2010 Oct 8;28(43):6970-6. doi: 10.1016/j.vaccine.2010.08.048. Epub 2010 Aug 21.

PMID:
20732470
12.

Design and evaluation in mice of a broadly protective meningococcal group B native outer membrane vesicle vaccine.

Zollinger WD, Donets MA, Schmiel DH, Pinto VB, Labrie JE 3rd, Moran EE, Brandt BL, Ionin B, Marques R, Wu M, Chen P, Stoddard MB, Keiser PB.

Vaccine. 2010 Jul 12;28(31):5057-67.

PMID:
20653107
13.

Characterization of an antibody depletion assay for analysis of bactericidal antibody specificity.

Zollinger WD, Moran EE, Schmiel DH.

Clin Vaccine Immunol. 2009 Dec;16(12):1789-95. doi: 10.1128/CVI.00255-09. Epub 2009 Oct 14.

14.
15.

Immunogenicity and safety testing of a group B intranasal meningococcal native outer membrane vesicle vaccine.

Katial RK, Brandt BL, Moran EE, Marks S, Agnello V, Zollinger WD.

Infect Immun. 2002 Feb;70(2):702-7.

16.

Safety and immunogenicity testing of an intranasal group B meningococcal native outer membrane vesicle vaccine in healthy volunteers.

Drabick JJ, Brandt BL, Moran EE, Saunders NB, Shoemaker DR, Zollinger WD.

Vaccine. 1999 Aug 20;18(1-2):160-72.

PMID:
10501246
17.

Immunogenicity of intranasally administered meningococcal native outer membrane vesicles in mice.

Saunders NB, Shoemaker DR, Brandt BL, Moran EE, Larsen T, Zollinger WD.

Infect Immun. 1999 Jan;67(1):113-9.

18.

A randomized, placebo-controlled study of oral cimetidine as an immunopotentiator of parenteral immunization with a group B meningococcal vaccine.

Drabick JJ, Tang DB, Moran EE, Trofa AF, Foster JS, Zollinger WD.

Vaccine. 1997 Jul;15(10):1144-8.

PMID:
9269060
20.

A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.

Bhattacharjee AK, Opal SM, Taylor R, Naso R, Semenuk M, Zollinger WD, Moran EE, Young L, Hammack C, Sadoff JC, Cross AS.

J Infect Dis. 1996 May;173(5):1157-63.

PMID:
8627067
22.

Antibodies to meningococcal H.8 (Lip) antigen fail to show bactericidal activity.

Bhattacharjee AK, Moran EE, Zollinger WD.

Can J Microbiol. 1990 Feb;36(2):117-22.

PMID:
2110857
23.

Purification and characterization of H.8 antigen from group B Neisseria meningitidis.

Bhattacharjee AK, Moran EE, Ray JS, Zollinger WD.

Infect Immun. 1988 Apr;56(4):773-8.

24.

Human bactericidal antibody response to meningococcal outer membrane protein vaccines.

Zollinger WD, Boslego J, Frøholm LO, Ray JS, Moran EE, Brandt BL.

Antonie Van Leeuwenhoek. 1987;53(6):403-11.

PMID:
3130779
25.

Monoclonal antibodies to serotype 2 and serotype 15 outer membrane proteins of Neisseria meningitidis and their use in serotyping.

Zollinger WD, Moran EE, Connelly H, Mandrell RE, Brandt B.

Infect Immun. 1984 Oct;46(1):260-6.

Supplemental Content

Loading ...
Support Center